[
  {
    "ts": "2026-02-18T12:30:00+00:00",
    "headline": "BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care",
    "summary": "BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers",
    "url": "https://finance.yahoo.com/news/brainsway-reports-cigna-evernorth-behavioral-123000606.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e3925b40-8076-3b63-9da7-3df8eb1d07cb",
      "content": {
        "id": "e3925b40-8076-3b63-9da7-3df8eb1d07cb",
        "contentType": "STORY",
        "title": "BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care",
        "description": "",
        "summary": "BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers",
        "pubDate": "2026-02-18T12:30:00Z",
        "displayTime": "2026-02-18T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/7fd5c54838c61c5a8cb348e35adfaa08",
          "originalWidth": 1716,
          "originalHeight": 1250,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J_NTMg01w.nsTheG2oWpSA--~B/aD0xMjUwO3c9MTcxNjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7fd5c54838c61c5a8cb348e35adfaa08.cf.webp",
              "width": 1716,
              "height": 1250,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t_W7qnbUuckYNu0dBpnbOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7fd5c54838c61c5a8cb348e35adfaa08.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/brainsway-reports-cigna-evernorth-behavioral-123000606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/brainsway-reports-cigna-evernorth-behavioral-123000606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BWAY"
            },
            {
              "symbol": "BRSYF"
            },
            {
              "symbol": "CI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]